Loading articles...
Eight articles in 2022Q4 marked a coverage peak for Leigh Drogen as crypto’s FTX-era reckoning put market analysis and research claims under scrutiny.
Leigh Drogen appears in this coverage principally as a market-minded technology and crypto commentator, closely associated with the @ldrogen account and cited around digital-asset debates, platform trends, and disputed research claims. The available stories place him in the conversation rather than as the central operator of the companies being covered.
Coverage concentrated in late 2022, with the 2022Q4 peak coinciding with the collapse-driven reassessment of crypto firms and tokens. Stories on Mazars pausing crypto proof-of-reserves work and deleting Binance’s report, and on Solana’s founders trying to separate SOL from FTX’s stain, supply the immediate backdrop; FTX and Alameda are the most prominent recurring co-entities around Drogen in this period.
The central tension is between promotional or simplified crypto narratives and skeptical evaluation of market evidence. Drogen’s recorded dispute with the Jump paper argues that its result depends on omitted filtering, while his reaction to an “I was wrong” label underscores a combative, public-facing style of challenging claims. That skepticism sits alongside coverage of Coinbase, FTX, Alameda, Solana, and Bitcoin during a period when credibility, disclosures, and token-market assumptions were under pressure.
If crypto coverage continues to be shaped by post-FTX demands for verifiable evidence, commentators who interrogate methodology may remain relevant to how investors and readers assess token research and exchange-linked narratives. The corpus does not establish whether Drogen’s critiques changed company policy or market outcomes, but it does show that his visibility rose when trust in the sector’s data and assurances was most contested.
Leigh Drogen has appeared in 47 articles since 2016-07. Coverage peaked in 2022Q4 with 8 articles. Frequently mentioned alongside @ldrogen, Alameda, FTX, Apple.